Ely Benaim
Geen lopende functies
Vermogen: 351 857 $ op 30-04-2024
Loopbaan van Ely Benaim
Eerdere bekende functies van Ely Benaim
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NOVOCURE LIMITED | Hoofd Techniek/Wetenschap/O&O | 01-04-2019 | 17-01-2023 |
| REXAHN PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-02-2015 | 31-03-2019 |
| Berg Pharma LLC | Hoofd Techniek/Wetenschap/O&O | 01-01-2013 | 01-01-2015 |
| Algemeen Adviseur | 01-01-2013 | 01-01-2015 | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | 01-01-2011 | 01-01-2013 |
| SANGAMO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2007 | 01-01-2010 |
| University of Tennessee | Corporate Officer/Principal | - | - |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Corporate Officer/Principal | - | - |
Opleiding van Ely Benaim
| Central University of Venezuela | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| Venezuela | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Salmedix, Inc.
Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA. | Health Technology |
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
| Berg Pharma LLC | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Ely Benaim
- Ervaring
